GHRH plus GHRP-6 diagnostic test
In a multicentre study of 125 adults with pituitary disease and 125 healthy controls, a test using GHRH together with GHRP-6 produced far larger growth hormone peaks in controls (average about 59 micrograms per litre) than in patients (about 4), a wider gap than the insulin tolerance test showed (about 14 versus 0.5). The authors proposed a cut-off for deficiency and reported no side effects during testing. This supports using the combination as a diagnostic stimulus. It is not a test of treatment.
- Study type
- Human trial
- Population
- Human adults: 125 with organic pituitary disease and 125 healthy controls, multicentre
- Source
- 1 Popovic et al., 2000
Limitation: GHRP-6 was tested together with GHRH, not on its own.
Limitations in full
GHRP-6 was tested together with GHRH, not on its own. The abstract gives no sensitivity or specificity figures. It tests a diagnostic use, not any treatment effect.